PRL and benign prostatic hyperplasia: The in vivo Pb-PRL-tg mouse BPH model also confirmed increased macrophage number and CCL3 expression in BPH, and targeting stromal AR via deletion of the stromal fibromuscular AR in the Pb-PRL-tg mouse BPH model reduced infiltrating macrophage number and CCL3 expression levels in the prostate.